For any administration requiring a written directive, a licensee must develop, implement, and maintain written procedures to provide high confidence that:
the patient's or human research subject's identity is verified before each administration; and
At a minimum, the procedures required by item A must address the following that are applicable to the licensee's use of radioactive material:
verifying that the administration is in accordance with the treatment plan, if applicable, and the written directive;
verifying that any computer-generated dose calculations are correctly transferred into the consoles of therapeutic medical units authorized under part 4731.4404 or 4731.4463;
determining, for permanent implant brachytherapy, within 60 calendar days from the date the implant was performed, the total source strength administered outside of the treatment site compared to the total source strength documented in the post-implantation portion of the written directive, unless a written justification of patient unavailability is documented.
29 SR 755; 33 SR 1440; 46 SR 791
May 26, 2022
Official Publication of the State of Minnesota
Revisor of Statutes